Joseph B. El-Khoury, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 30 | 2020 | 1351 | 4.060 |
Why?
|
| Receptors, Scavenger | 10 | 2017 | 123 | 1.590 |
Why?
|
| Amyloid beta-Peptides | 18 | 2019 | 3832 | 1.450 |
Why?
|
| Receptors, Immunologic | 11 | 2019 | 1411 | 1.090 |
Why?
|
| Alzheimer Disease | 16 | 2019 | 8547 | 1.060 |
Why?
|
| Confusion | 2 | 2018 | 279 | 1.040 |
Why?
|
| Phagocytes | 4 | 2013 | 296 | 0.820 |
Why?
|
| Phagocytosis | 15 | 2019 | 1535 | 0.800 |
Why?
|
| Scavenger Receptors, Class A | 6 | 2017 | 52 | 0.700 |
Why?
|
| Macrophages | 18 | 2020 | 5745 | 0.690 |
Why?
|
| Receptors, Lipoprotein | 5 | 2002 | 88 | 0.650 |
Why?
|
| Monocytes | 8 | 2020 | 2575 | 0.640 |
Why?
|
| Roseolovirus Infections | 1 | 2018 | 50 | 0.590 |
Why?
|
| Herpesvirus 6, Human | 1 | 2018 | 97 | 0.580 |
Why?
|
| Meningoencephalitis | 1 | 2018 | 83 | 0.580 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 1084 | 0.570 |
Why?
|
| Complement C1q | 2 | 2016 | 94 | 0.550 |
Why?
|
| Adrenoleukodystrophy | 1 | 2017 | 143 | 0.510 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2013 | 1827 | 0.500 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 1900 | 0.480 |
Why?
|
| User-Computer Interface | 1 | 2020 | 1403 | 0.440 |
Why?
|
| Cryptococcus neoformans | 3 | 2009 | 121 | 0.420 |
Why?
|
| Heterozygote | 1 | 2019 | 2798 | 0.420 |
Why?
|
| Receptors, CCR2 | 3 | 2010 | 215 | 0.410 |
Why?
|
| Membrane Glycoproteins | 4 | 2019 | 3707 | 0.410 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 857 | 0.410 |
Why?
|
| Astrocytes | 3 | 2017 | 1338 | 0.410 |
Why?
|
| Flow Cytometry | 4 | 2019 | 5870 | 0.410 |
Why?
|
| Chemokines | 5 | 2010 | 962 | 0.390 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7850 | 0.390 |
Why?
|
| Central Nervous System Infections | 1 | 2012 | 61 | 0.380 |
Why?
|
| Brain | 11 | 2020 | 26951 | 0.380 |
Why?
|
| Triterpenes | 1 | 2011 | 81 | 0.370 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 521 | 0.370 |
Why?
|
| Inflammation | 6 | 2018 | 10756 | 0.370 |
Why?
|
| Models, Immunological | 2 | 2017 | 513 | 0.360 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2010 | 663 | 0.350 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 8986 | 0.350 |
Why?
|
| Glioblastoma | 3 | 2020 | 3484 | 0.340 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 1599 | 0.340 |
Why?
|
| Mice | 33 | 2020 | 81208 | 0.330 |
Why?
|
| Parasites | 1 | 2012 | 161 | 0.330 |
Why?
|
| Candida albicans | 2 | 2010 | 374 | 0.330 |
Why?
|
| Fungi | 1 | 2012 | 339 | 0.330 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2003 | 343 | 0.320 |
Why?
|
| Animals | 43 | 2020 | 167963 | 0.320 |
Why?
|
| Signal Transduction | 11 | 2019 | 23376 | 0.320 |
Why?
|
| Neuroimmunomodulation | 1 | 2010 | 177 | 0.320 |
Why?
|
| Macrophages, Peritoneal | 2 | 2013 | 237 | 0.310 |
Why?
|
| Immune System | 1 | 2013 | 798 | 0.290 |
Why?
|
| Encephalitis | 1 | 2010 | 437 | 0.270 |
Why?
|
| Immunity, Innate | 4 | 2017 | 3047 | 0.270 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4407 | 0.260 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 2005 | 0.260 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1167 | 0.250 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1019 | 0.250 |
Why?
|
| Glioma | 1 | 2020 | 3420 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 14 | 2020 | 22023 | 0.240 |
Why?
|
| Reactive Oxygen Species | 9 | 2016 | 2138 | 0.240 |
Why?
|
| Mice, Transgenic | 6 | 2020 | 9530 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8515 | 0.230 |
Why?
|
| Plaque, Amyloid | 3 | 2019 | 758 | 0.230 |
Why?
|
| Neurons | 3 | 2019 | 9426 | 0.220 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 1447 | 0.220 |
Why?
|
| Oxazolidinones | 1 | 2003 | 97 | 0.210 |
Why?
|
| Vancomycin Resistance | 1 | 2003 | 126 | 0.210 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2018 | 5649 | 0.210 |
Why?
|
| Apoptosis | 2 | 2016 | 9501 | 0.210 |
Why?
|
| Enterococcus faecium | 1 | 2003 | 101 | 0.210 |
Why?
|
| Cytokines | 6 | 2020 | 7343 | 0.210 |
Why?
|
| Caenorhabditis elegans | 2 | 2009 | 1444 | 0.200 |
Why?
|
| Ligands | 6 | 2017 | 3276 | 0.200 |
Why?
|
| Carrier Proteins | 1 | 2015 | 4938 | 0.200 |
Why?
|
| Acetamides | 1 | 2003 | 256 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 11903 | 0.190 |
Why?
|
| Fallopian Tube Diseases | 1 | 2001 | 60 | 0.190 |
Why?
|
| Bacteria | 1 | 2012 | 2199 | 0.180 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 4810 | 0.180 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 1885 | 0.180 |
Why?
|
| Ovarian Diseases | 1 | 2001 | 137 | 0.180 |
Why?
|
| Mice, Knockout | 11 | 2019 | 14372 | 0.170 |
Why?
|
| Cell Adhesion | 8 | 2009 | 3094 | 0.170 |
Why?
|
| Cells, Cultured | 12 | 2017 | 18957 | 0.170 |
Why?
|
| Scavenger Receptors, Class B | 5 | 2002 | 84 | 0.170 |
Why?
|
| Brain Abscess | 1 | 2020 | 120 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2020 | 4122 | 0.160 |
Why?
|
| Mucormycosis | 1 | 2020 | 103 | 0.160 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 419 | 0.160 |
Why?
|
| Foscarnet | 1 | 2018 | 35 | 0.150 |
Why?
|
| Terminology as Topic | 2 | 2017 | 1535 | 0.150 |
Why?
|
| Graft vs Host Reaction | 1 | 2018 | 103 | 0.150 |
Why?
|
| Moths | 2 | 2010 | 81 | 0.150 |
Why?
|
| Abscess | 1 | 2001 | 605 | 0.150 |
Why?
|
| Genes, env | 1 | 1997 | 95 | 0.150 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2007 | 39 | 0.150 |
Why?
|
| Lysophosphatidylcholines | 1 | 2017 | 77 | 0.150 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 62 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 261 | 0.140 |
Why?
|
| Pseudomonas Infections | 1 | 2001 | 623 | 0.140 |
Why?
|
| Milk Proteins | 1 | 2017 | 163 | 0.140 |
Why?
|
| Free Radical Scavengers | 1 | 1998 | 211 | 0.140 |
Why?
|
| Disease Progression | 2 | 2015 | 13502 | 0.140 |
Why?
|
| RNA, Neoplasm | 1 | 2019 | 749 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 16939 | 0.140 |
Why?
|
| Distal Myopathies | 1 | 2016 | 18 | 0.140 |
Why?
|
| Receptors, Fc | 2 | 1997 | 534 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 981 | 0.130 |
Why?
|
| Facial Paralysis | 1 | 2020 | 345 | 0.130 |
Why?
|
| Chemokine CX3CL1 | 1 | 2015 | 64 | 0.130 |
Why?
|
| Humans | 41 | 2020 | 760621 | 0.130 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 530 | 0.130 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18137 | 0.130 |
Why?
|
| HEK293 Cells | 2 | 2016 | 4264 | 0.120 |
Why?
|
| Chemokine CCL2 | 2 | 2010 | 605 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1088 | 0.120 |
Why?
|
| Antibodies | 3 | 2017 | 2421 | 0.120 |
Why?
|
| Autopsy | 1 | 2018 | 1007 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 820 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2020 | 1895 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3442 | 0.110 |
Why?
|
| Orthomyxoviridae | 1 | 2015 | 148 | 0.110 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 177 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1342 | 0.110 |
Why?
|
| Scavenger Receptors, Class F | 1 | 2013 | 16 | 0.110 |
Why?
|
| Cyclic AMP | 1 | 1997 | 1456 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1608 | 0.110 |
Why?
|
| Cholesteatoma | 1 | 2013 | 28 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2003 | 1150 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2020 | 817 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1832 | 0.110 |
Why?
|
| Endocytosis | 1 | 2017 | 959 | 0.100 |
Why?
|
| Aging | 2 | 2009 | 8651 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 726 | 0.100 |
Why?
|
| Postmenopause | 1 | 2001 | 2509 | 0.100 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 250 | 0.100 |
Why?
|
| Receptors, Chemokine | 1 | 2015 | 655 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2007 | 1167 | 0.100 |
Why?
|
| Solubility | 2 | 2013 | 1088 | 0.100 |
Why?
|
| Cell Communication | 1 | 2019 | 1653 | 0.100 |
Why?
|
| Actins | 2 | 2007 | 2049 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1866 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2019 | 3790 | 0.100 |
Why?
|
| Cryptococcosis | 2 | 2009 | 104 | 0.090 |
Why?
|
| Otitis Media | 1 | 2013 | 285 | 0.090 |
Why?
|
| Neurotoxins | 1 | 2011 | 240 | 0.090 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2009 | 29 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2015 | 530 | 0.090 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 548 | 0.090 |
Why?
|
| Collagen | 3 | 1996 | 2636 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 2209 | 0.090 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2009 | 97 | 0.090 |
Why?
|
| Candidiasis | 2 | 2010 | 363 | 0.080 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2010 | 114 | 0.080 |
Why?
|
| Cricetulus | 1 | 2011 | 815 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 1881 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2017 | 1817 | 0.080 |
Why?
|
| Cerebellum | 1 | 2016 | 1496 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2015 | 1370 | 0.080 |
Why?
|
| Presenilin-1 | 1 | 2013 | 660 | 0.080 |
Why?
|
| CHO Cells | 1 | 2011 | 1389 | 0.080 |
Why?
|
| Protein Binding | 4 | 2016 | 9335 | 0.080 |
Why?
|
| Crosses, Genetic | 2 | 2007 | 751 | 0.080 |
Why?
|
| Temporal Bone | 1 | 2013 | 683 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2013 | 10182 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12965 | 0.080 |
Why?
|
| Chemokine CXCL9 | 1 | 2008 | 135 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2013 | 2025 | 0.070 |
Why?
|
| Cricetinae | 1 | 2011 | 2427 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1999 | 221 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2018 | 1394 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2016 | 5761 | 0.070 |
Why?
|
| Receptors, CXCR3 | 1 | 2008 | 238 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 348 | 0.070 |
Why?
|
| Chemokine CXCL10 | 1 | 2008 | 316 | 0.070 |
Why?
|
| Gene Expression | 2 | 2017 | 7588 | 0.070 |
Why?
|
| Malaria, Cerebral | 1 | 2008 | 136 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1628 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3844 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2001 | 4215 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2192 | 0.070 |
Why?
|
| Plasmids | 1 | 2011 | 2275 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 580 | 0.070 |
Why?
|
| Leukotriene B4 | 2 | 1999 | 280 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1347 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2009 | 554 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2018 | 3061 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2282 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2020 | 8035 | 0.060 |
Why?
|
| Fibrin | 2 | 1999 | 505 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7064 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2007 | 11071 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2019 | 698 | 0.060 |
Why?
|
| Proteomics | 1 | 2017 | 3817 | 0.060 |
Why?
|
| Lyme Disease | 1 | 2009 | 630 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2015 | 2044 | 0.050 |
Why?
|
| Chemotaxis | 2 | 2003 | 598 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 2159 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 866 | 0.050 |
Why?
|
| Glucose | 1 | 1994 | 4351 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6238 | 0.050 |
Why?
|
| Lipoproteins, LDL | 2 | 2009 | 641 | 0.050 |
Why?
|
| Peroxides | 1 | 2002 | 73 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6957 | 0.050 |
Why?
|
| Biological Assay | 1 | 2004 | 630 | 0.050 |
Why?
|
| Computational Biology | 1 | 2013 | 3505 | 0.050 |
Why?
|
| Male | 8 | 2020 | 359744 | 0.050 |
Why?
|
| Tyrosine | 3 | 2007 | 1438 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2414 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10446 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2003 | 4357 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 869 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3204 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2004 | 911 | 0.040 |
Why?
|
| Neutrophils | 3 | 1999 | 3767 | 0.040 |
Why?
|
| Dysarthria | 1 | 2020 | 58 | 0.040 |
Why?
|
| HIV-1 | 1 | 1997 | 6849 | 0.040 |
Why?
|
| Opsonin Proteins | 1 | 2000 | 147 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22053 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3804 | 0.040 |
Why?
|
| Teichoic Acids | 1 | 2000 | 70 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1249 | 0.040 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 91 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1064 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 2020 | 172 | 0.040 |
Why?
|
| Peritoneal Dialysis | 1 | 2020 | 157 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 6131 | 0.040 |
Why?
|
| Empathy | 1 | 2003 | 473 | 0.040 |
Why?
|
| Amyloid | 1 | 2003 | 842 | 0.040 |
Why?
|
| Cell Line | 3 | 2009 | 15620 | 0.040 |
Why?
|
| Cell Movement | 3 | 2008 | 5206 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2020 | 337 | 0.040 |
Why?
|
| Paxillin | 1 | 2007 | 86 | 0.040 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2007 | 87 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2013 | 8313 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18416 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 1997 | 286 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 438 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 732 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1997 | 778 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 153 | 0.030 |
Why?
|
| Fetus | 1 | 2002 | 1859 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2009 | 5039 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2015 | 157 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 266 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 590 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 333 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 13451 | 0.030 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1994 | 151 | 0.030 |
Why?
|
| Earache | 1 | 2013 | 14 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1994 | 348 | 0.030 |
Why?
|
| Rats | 2 | 2002 | 23711 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 231 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 220352 | 0.030 |
Why?
|
| Female | 8 | 2020 | 391270 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1994 | 575 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 12922 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1204 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 17624 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 149 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 687 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17790 | 0.020 |
Why?
|
| Hearing Loss, Conductive | 1 | 2013 | 159 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 474 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 29932 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2003 | 478 | 0.020 |
Why?
|
| Zymosan | 1 | 1991 | 136 | 0.020 |
Why?
|
| Protein Folding | 1 | 2015 | 867 | 0.020 |
Why?
|
| HIV Infections | 1 | 1997 | 17165 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2015 | 559 | 0.020 |
Why?
|
| United States | 2 | 2017 | 72461 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2000 | 6216 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 581 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 1407 | 0.020 |
Why?
|
| Immunization | 1 | 2015 | 1227 | 0.020 |
Why?
|
| src-Family Kinases | 2 | 2003 | 535 | 0.020 |
Why?
|
| Slovenia | 1 | 2009 | 21 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 1484 | 0.020 |
Why?
|
| Hyphae | 1 | 2010 | 52 | 0.020 |
Why?
|
| Risk Factors | 2 | 2015 | 74359 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 995 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4573 | 0.020 |
Why?
|
| Tuftsin | 1 | 2009 | 4 | 0.020 |
Why?
|
| Serine | 1 | 2013 | 830 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3215 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5125 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 700 | 0.020 |
Why?
|
| Cattle | 1 | 1994 | 3847 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 1246 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 630 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 877 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2008 | 258 | 0.020 |
Why?
|
| Plasmodium berghei | 1 | 2008 | 159 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2020 | 5961 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2118 | 0.020 |
Why?
|
| Hemocytes | 1 | 2005 | 44 | 0.020 |
Why?
|
| Fever | 1 | 2013 | 1617 | 0.020 |
Why?
|
| Headache | 1 | 2013 | 1249 | 0.020 |
Why?
|
| Peptides | 1 | 1996 | 4354 | 0.010 |
Why?
|
| Foam Cells | 1 | 2003 | 68 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20509 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 110 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2009 | 2316 | 0.010 |
Why?
|
| Adult | 4 | 2020 | 219994 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12808 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2298 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1991 | 2415 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 814 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 653 | 0.010 |
Why?
|
| Virulence | 1 | 2005 | 1298 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2250 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1998 | 2222 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 42063 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12766 | 0.010 |
Why?
|
| Recurrence | 1 | 2013 | 8482 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2005 | 749 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1588 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 9585 | 0.010 |
Why?
|
| Scopoletin | 1 | 1998 | 2 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6544 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8056 | 0.010 |
Why?
|
| Catalase | 1 | 1998 | 216 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 830 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 818 | 0.010 |
Why?
|
| Calcium | 1 | 1991 | 5725 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9287 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 169152 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1997 | 112 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15840 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 65017 | 0.010 |
Why?
|
| Acetylation | 1 | 1998 | 1062 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 3969 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5781 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1142 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2440 | 0.010 |
Why?
|
| Quinolinium Compounds | 1 | 1994 | 10 | 0.010 |
Why?
|
| Child | 1 | 2003 | 79806 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 87810 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 1854 | 0.010 |
Why?
|
| Models, Biological | 2 | 2002 | 9467 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 4550 | 0.010 |
Why?
|
| Benzoxazoles | 1 | 1994 | 89 | 0.010 |
Why?
|
| Laminin | 1 | 1995 | 405 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3517 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1994 | 353 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1998 | 1016 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1995 | 801 | 0.010 |
Why?
|
| Acridine Orange | 1 | 1991 | 28 | 0.010 |
Why?
|
| Thioglycolates | 1 | 1991 | 38 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 1991 | 91 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58995 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6898 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1991 | 138 | 0.010 |
Why?
|
| Magnesium | 1 | 1994 | 810 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1998 | 9185 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4490 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 751 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1994 | 1993 | 0.000 |
Why?
|
| Time Factors | 2 | 2003 | 40165 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1913 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 58741 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36290 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1991 | 2651 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4541 | 0.000 |
Why?
|